Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer. J Thorac Oncol. 2015 Jul; 10(7):1099-106.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Clinical Trials as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Disease-Free Survival
Endpoint Determination
Female
Humans
Lung Neoplasms
Male
Middle Aged
Randomized Controlled Trials as Topic
Small Cell Lung Carcinoma
Survival Analysis
Young Adult

authors with profiles

Everett E. Vokes